Genzyme Battles an Old Adversary

Fifteen months ago, Genzyme and Transkaryotic Therapies of Cambridge decided to kiss and make up. It didn't last. A new squabble over disputed intellectual property has surfaced between the former adversaries. Genzyme sued TKT in an Israeli court, claiming that the firm's method of purifying a treatment for Gaucher's disease infringed on Genzyme's proprietary technology. TKT claimed Genzyme wanted court permission to seize and destroy TKT's experimental treatment, which is being used in a clinical trial in Israel.

The Boston Globe (http://www.boston.com/business/technology/biotechnology/articles/2005/01/25/genzyme_battles_an_old_adversary/)